Who owns HALOZYME THERAPEUTICS?
- CUSIP Number: 40637had1
Tip: Access positions for across all investors
Analyze quarterly positions in Halozyme Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Halozyme Therapeutics stock
Who bought or sold HALOZYME THERAPEUTICS this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Wellesley Investment Advisors | 61M | $53B | -5% | Dec 2023 |
|
| Davidson Kempner Capital Management | 50M | $44M | 0% | Mar 2024 |
|
| Lazard Asset Management | 37M | $32M | 105% | Dec 2023 |
|
| Citigroup | 23M | $21M | 13% | Mar 2024 |
|
| Aviva | 22M | $19M | 10% | Mar 2024 |
|
| Wells Fargo & Company | 15M | $14M | 3% | Mar 2024 |
|
| Ameriprise Financial | 15M | $14M | -6% | Mar 2024 |
|
| Tenor Capital Management | 15M | $13B | 25% | Mar 2024 |
|
| Susquehanna International | 13M | $11M | -18% | Mar 2024 |
|
| Victory Capital Management | 12M | $11M | 28% | Mar 2024 |
|
| Citadel Advisors | 11M | $10M | -30% | Mar 2024 |
|
| III Capital Management | 11M | $10M | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 10M | $9.0M | 8% | Mar 2024 |
|
| Wolverine Asset Management | 9.6M | $8.5M | 0% | Mar 2024 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 9.3M | $8.2M | 0% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 9.1M | $8.1M | 3732% | Mar 2024 |
|
| Shenkman Capital Management | 8.4M | $7.6B | 5% | Mar 2024 |
|
| Millennium Management | 7.0M | $6.2M | 0% | Mar 2024 |
|
| BlackRock | 6.6M | $5.9M | 26% | Mar 2024 |
|
| D. E. Shaw & Co | 6.1M | $5.4M | -60% | Mar 2024 |
|
| Verition Fund Management | 5.0M | $4.4M | 100% | Mar 2024 |
|
| Calamos Advisors | 4.6M | $4.1M | 0% | Mar 2024 |
|
| Bank of America Corporation | 4.6M | $4.0M | -1% | Mar 2024 |
|
| Sonora Investment Management Group | 4.2M | $3.7M | -3% | Mar 2024 |
|
| Man Group | 4.0M | $3.5M | -27% | Mar 2024 |
|
| Franklin Resources | 3.4M | $3.1M | 100% | Mar 2024 |
|
| SSI Investment Management | 3.1M | $2.6M | -33% | Dec 2023 |
|
| Flossbach Von Storch | 2.9M | $2.5M | 0% | Mar 2024 |
|
| Palisade Capital Management | 2.6M | $2.3M | -7% | Mar 2024 |
|
| Amundi | 2.3M | $2.0M | 0% | Mar 2024 |
|
| Lombard Odier Asset Management | 1.8M | $1.6M | 0% | Mar 2024 |
|
| Penn Mutual Asset Management | 1.6M | $1.4M | 0% | Mar 2024 |
|
| Royal Bank of Canada | 1.2M | $1.1M | 0% | Mar 2024 |
|
| Barclays | 1.2M | $1.0M | 179% | Mar 2024 |
|
| CSS | 703k | $624k | 134% | Mar 2024 |
|
| Boothbay Fund Management | 659k | $585k | 100% | Mar 2024 |
|
| Bnp Paribas Investment Partners | 650k | $575k | -61% | Mar 2024 |
|
| Bank of New York Mellon | 600k | $533k | 0% | Mar 2024 |
|
| KBC Group NV | 300k | $266k | 0% | Mar 2024 |
|
| Union Investments & Development | 200k | $178k | 0% | Mar 2024 |
|
| Cetera Investment Advisers | 193k | $171k | 100% | Mar 2024 |
|
| D.A. Davidson & Co. | 180k | $158k | 0% | Mar 2024 |
|
| CNH Partners | 140k | $125k | 0% | Mar 2024 |
|
| Argent Trust | 70k | $62k | 0% | Mar 2024 |
|
| Foresight Capital Management Advisors | 44k | $39k | 0% | Mar 2024 |
|
| Mason & Associates | 44k | $39k | 100% | Mar 2024 |
|
| HPM Partners | 43k | $235k | 1% | Mar 2024 |
|
| Goldstein Advisors | 19k | $17k | -21% | Mar 2024 |
|
| Nbc Securities | 13k | $11k | -52% | Mar 2024 |
|
| Brian McDonald | 10k | $8.8k | -44% | Mar 2024 |
|
| Northwestern Mutual Wealth Management Company | 4.0k | $3.5k | -94% | Mar 2024 |
|
| Laffer Investments | 2.1k | $1.9M | -4% | Mar 2024 |
|
| Candriam Luxembourg S.C.A. | 400.00 | $355k | -50% | Mar 2024 |
|
Who sold out of Halozyme Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Linden Advisors | Sep 2023 | 63M | $53B |
| Readystate Asset Management | Dec 2023 | 13M | $11M |
| Daiwa Securities Group | Dec 2023 | 2.5M | $2.2M |
| La Banque Postale Asset Management SA | Dec 2023 | 1.0M | $864k |
| Groupama Asset Managment | Dec 2023 | 750k | $648k |
| Morgan Stanley | Sep 2023 | 297k | $251k |
| American Century Companies | Sep 2023 | 283k | $240k |
| Financial Network Investment Corporation | Sep 2023 | 107k | $90k |
| Multi-Financial Securities | Sep 2023 | 101k | $85k |